Canine Cancer Screening Market Key Highlights:
- Market Size (2024): USD 1,398 Million
- Projected Market Size (2034): USD 2,110 Million
- CAGR (2024-2034): 4.2%
Pricing Analysis:
- Price Growth
- Regional Variations
Market Historic Sales
- Total sales volume, year-over-year growth, product categories, and market share.
Revenue Estimation
- Forecasting future revenues based on historical data, market trends, and economic indicators.
Sales by Region
- Breakdown of sales performance across different geographical areas.
Revenue by Manufacturer
- Analysis of revenue contributions from different manufacturers in the market.
Canine Cancer Screening Market Definition
The growing amount of disposable income has led to widespread adoption of the pet care industry. Among the large portfolio of available species, Canines are the most preferred companions. Due to their adaptable nature and trainable defensive and offensive skills, dog breeds have undergone decades worth of cross-breeding and other genetic manipulations. This has given the world several breeds having certain overdeveloped traits. However, this synthetic manipulation of genes has resulted in a rise in conditions such as cardiovascular disorders and cancer.
- It is estimated that, on average, 1 in every 4 dogs is diagnosed with some form of neoplasia, and almost half of dogs over the age of 10 will develop cancer.
Although dogs develop cancer at the same rate as humans, limited awareness and a lack of funding lead to a much larger fatality index. The first step towards veterinary healthcare in oncology is better diagnostic services. The canine cancer screening market involves a variety of diagnostic technologies, including testing facilities, biopsy apparatus and reagents, imaging technologies such as X-rays, ultrasounds and MRIs, and blood-based analysis services.
The canine cancer screening market has recently gained traction due to rising investments in the veterinary healthcare industry, which is responding to the rising recognition of animal rights. Faster detection methods combined with automation and bulk processing are the most widespread developments in the industry. These technologies are often combined with traditional screening methods for quicker and more accurate results.
Canine Cancer Screening Market Segmentation:
By Test
- Liquid Biopsy (Blood-based tests)
- Tissue Biopsy
- Genomic Testing
- Biomarker Tests
By Technology
- Next-Generation Sequencing (NGS)
- Polymerase Chain Reaction (PCR)
- Immunohistochemistry (IHC)
- Flow Cytometry
- In Situ Hybridization
By Cancer
- Lymphoma
- Mast Cell Tumours
- Osteosarcoma
- Hemangiosarcoma
By End User
- Veterinary Clinics
- Veterinary Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
- Pet Owners (Home-based Testing Kits
Pressure Infusion Cuffs Market Companies:
- IDEXX
- Mars Pedtcare
- Zoetis
- PetDx
- Molecular Diagnostics (MDxHealth)
- Biomérieux SA
- OncoK9
- Antech Diagnostics
- VolitionRx Limited
- Oncotect
- Heska Corporation
For any questions about this dataset or to discuss customization options, please write to us at sales@statifacts.com
